- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Transgene (TRNG)
Transgene stock price live, this page displays EPA TRNG stock exchange data. View the TRNG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Transgene real time stock price chart below.
What Is the Transgene Stock Price Today?
The Transgene stock price today is 0.838.
What Is the Stock Symbol for Transgene?
The stock ticker symbol for Transgene is TRNG.
Is TRNG the Same as $TRNG?
$TRNG is a common way to refer to the Transgene ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Transgene Trade On?
Transgene is listed and trades on the Paris stock exchange.
Is Transgene a Good Stock to Buy?
Determining whether Transgene—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Transgene share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TRNG quote. (ISIN: FR0005175080)
What Is the Transgene Stock Price Today?
The Transgene stock price today is 0.838.
What Is the Stock Symbol for Transgene?
The stock ticker symbol for Transgene is TRNG.
Is TRNG the Same as $TRNG?
$TRNG is a common way to refer to the Transgene ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Transgene Trade On?
Transgene is listed and trades on the Paris stock exchange.
Is Transgene a Good Stock to Buy?
Determining whether Transgene—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Transgene share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TRNG quote. (ISIN: FR0005175080)
0.838
-0.002(-0.24%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.827
0.866
52 wk Range
0.705
1.500
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.8270.866
52 wk Range
0.7051.500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TRNG Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
1.100
Upside
+31.26%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 1.100
(+31.26% Upside)
Earnings
Latest Release
Apr 29, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare TRNG to Peers and Sector
Metrics to compare | TRNG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTRNGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.1x | −3.1x | −0.3x | |
PEG Ratio | −0.57 | −0.06 | 0.00 | |
Price / Book | 1.9x | 0.9x | 2.6x | |
Price / LTM Sales | 31.9x | 13.1x | 3.1x | |
Upside (Analyst Target) | 31.0% | 143.3% | 48.5% | |
Fair Value Upside | Unlock | 5.0% | 6.3% | Unlock |
Transgene SA, a biotechnology company, designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer in France. It involved in developing TG4050, a therapeutic vaccine that is in Phase II clinical trial for the treatment of head and neck cancers; TG4001, a therapeutic vaccine, which is in Phase II clinical trial for the treatment of human papillomavirus (HPV 16) positive cancers; and BT-001, an oncolytic virus, which is in Phase I/II clinical trial for the treatment of solid tumors. The company also develops TG6050 for the treatment of non-small cell lung cancer that is in Phase 1 clinical trial. It has strategic collaboration agreements with NEC Corporation and NEC Bio, BioInvent, Merck & Co., Inc., Oxford Biomedica, Stamford, SillaJen, and ProBioGen. The company was incorporated in 1979 and is headquartered in Illkirch-Graffenstaden, France. Transgene SA is a subsidiary of TSGH SAS.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Transgene (TRNG) Stock Price Today?
The Transgene stock price today is 0.838 EUR.
What Stock Exchange Does Transgene Trade On?
Transgene is listed and trades on the Paris Stock Exchange.
What Is the Stock Symbol for Transgene?
The stock symbol for Transgene is "TRNG."
What Is the Transgene Market Cap?
As of today, Transgene market cap is 230.060M EUR.
What Is Transgene's Earnings Per Share (TTM)?
The Transgene EPS (TTM) is -0.260.
When Is the Next Transgene Earnings Date?
Transgene will release its next earnings report on Sep 24, 2026.
From a Technical Analysis Perspective, Is TRNG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Transgene Stock Split?
Transgene has split 4 times.
How Many Employees Does Transgene Have?
Transgene has 145 employees.
What is the current trading status of Transgene (TRNG)?
As of Aug 20, 2026, Transgene (TRNG) is trading at a price of 0.838 EUR, with a previous close of 0.840 EUR. The stock has fluctuated within a day range of 0.827 EUR to 0.866 EUR, while its 52-week range spans from 0.705 EUR to 1.500 EUR.
What Is Transgene (TRNG) Price Target According to Analysts?
The average 12-month price target for Transgene is 1.100 EUR, with a high estimate of 1.1 EUR and a low estimate of 1.1 EUR. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +31.26% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.